reports
Costamare Inc. Announces Availability of Its Annual Report on Form 20-...
Costamare Inc. Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2025 MONACO, March 04, 2026 (GLOBE NEWSWIRE) -- Costamare Inc. (the “Company”, “we” or “our”) (NYSE: CMRE) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission and can be accessed on the Company’s website, , in the “Investors” section under “Annual Reports”. Stockholders may also request a hard copy of the Annual Report, which includes the Company’s complete ...
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corpora...
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSK SCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and plans to report topline data in the second half of 2026 Responding to patients’ need for alternatives to existing anti-fungal therapies, SCYNEXIS plans to initiate an expanded access program for SCY-247 in the first half of 2026SCYNEXIS ended Q4 2025 with cash, cash equivalents and investments of $56...
COMPX REPORTS FOURTH QUARTER 2025 RESULTS
COMPX REPORTS FOURTH QUARTER 2025 RESULTS Dallas, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today net sales of $37.7 million for the fourth quarter of 2025 compared to $38.4 million in the same period of 2024. Operating income was $5.6 million in the fourth quarter of 2025 compared to $4.9 million in the same period of 2024. Net income was $4.7 million, or $.38 per basic and diluted common share, for the fourth quarter of 2025 compared to $4.5 million, or $.37 per basic and diluted common share, in the same period of 2024. Net sales...
Enviri Corporation Announces Early Termination of Hart-Scott-Rodino Ac...
Enviri Corporation Announces Early Termination of Hart-Scott-Rodino Act Waiting Period for Proposed Sale of Clean Earth to Veolia Transaction On Track for Mid-Year 2026 Closing PHILADELPHIA, March 04, 2026 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI) (“Enviri,” or the “Company”) today announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) in connection with the previously announced sale of Clean Earth to Veolia Environnement SA (“Veolia”). Termination of the waiting period satisfies a closing condition nece...
Castellum, Inc. Announces 2025 Unaudited Financial Results
Castellum, Inc. Announces 2025 Unaudited Financial Results VIENNA, Va., March 04, 2026 (GLOBE NEWSWIRE) -- Castellum, Inc. (“Castellum” “CTM”, “we” or the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces certain unaudited highlights of its operating results for its year ended December 31, 2025. Revenue for 2025 increased to $52.9 million, representing an $8.1 million (15.2%) increase over $44.8 million in 2024. Operating loss improved to $2.8 million, a $4.4 million year-over-year improvement ...
NN, Inc. Reports Fourth Quarter and Full Year 2025 Results
NN, Inc. Reports Fourth Quarter and Full Year 2025 Results NN delivers third consecutive year of successful transformation; completes majority of heavy spending NN forecasts fourth year of improvement, and a return to organic net sales growth in 2026 CHARLOTTE, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported its financial results for the fourth quarter and full-year ended December 31, 2025. Key results include: Finan...
Oculis Publishes Notifications of Transactions by Persons Discharging ...
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities ZUG, Switzerland, March 04, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment
COMPX DECLARES REGULAR QUARTERLY DIVIDEND
COMPX DECLARES REGULAR QUARTERLY DIVIDEND Dallas, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today that its board of directors has declared CompX’s regular quarterly dividend of thirty cents ($0.30) per share on its class A common stock, payable on March 24, 2026 to stockholders of record at the close of business on March 16, 2026. CompX is a leading manufacturer of security products and recreational marine components. * * * * Investor Relations Contact Bryan A. HanleySenior Vice President and TreasurerTel. 972-233-1700
Natural Resource Partners L.P. 2025 Form 10-K Now Available
Natural Resource Partners L.P. 2025 Form 10-K Now Available HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Natural Resource Partners L.P. (NYSE: NRP) announced today that it filed the partnership’s Annual Report Form 10-K for the period ended December 31, 2025 with the Securities and Exchange Commission on February 27, 2026. The report is available on NRP’s website at , and hard copies of the report may be requested free of charge at or by contacting the partnership at 1415 Louisiana Street, Suite 3325, Houston, TX 77002. Company Profile Natural Resource Partners L.P., a master limited pa...
Sachem Capital Corp. Announces Common and Preferred Dividends
Sachem Capital Corp. Announces Common and Preferred Dividends BRANFORD, Conn., March 04, 2026 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) (the “Company”), a real estate lender specializing in originating, underwriting, funding, servicing, and managing a portfolio of loans secured by first mortgages on real property, announced today that its Board of Directors (the “Board”) declared a quarterly dividend of $0.05 per common share to be paid on March 30, 2026 to shareholders of record as of the close of trading on the NYSE American on March 15, 2026. Additionally, the Boa...
Clarus Announces $0.025 Per Share Quarterly Dividend
Clarus Announces $0.025 Per Share Quarterly Dividend SALT LAKE CITY, March 04, 2026 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, announced that its board of directors has confirmed the Company’s regular quarterly cash dividend of $0.025 per share. The cash dividend will be paid on March 25, 2026, to all stockholders of record as of March 16, 2026. About Clarus CorporationHeadquartered in Salt Lake City, Utah, Clarus Corporation is a global leader in the design and development of best-in...
- David Barden
- Vikash Harlalka
Broadband Spring 2026 – A fine time for FWA
In this Broadband Spring report, we share a quick update on broadband industry trends from 4Q25 heading into 2026E. Industry net adds improved meaningfully in 4Q25 from a year ago but remained slightly below last year when we adjust for the loss of ACP. Net adds for the quarter were in line with the pre-pandemic norm but trailing twelve-month net adds remain below pre-pandemic levels. We take a deep-dive here into FWA’s continued strong momentum, by carrier, and how it fits into the overall broa...
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights Delivered $90.5 million in worldwide revenue for the full year of 2025, an 8% increase over the prior year and an increase of 7% on a constant currency basisAchieved worldwide revenue of $22.6 million for the fourth qua...
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Res...
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the fourth quarter and full year ended December 31, 2025 and initiated financial guidance for full year 2026. Recent Financial Highl...
ImmuCell Announces Unaudited Financial Results for the Year Ended Dece...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced its unaudited financial results for the year ended December 31, 2025. Management’s Discussion: “Today we are reporting 2025 net operating income of $1.6 million, an increase of $3.3 million compared to 2024. These results were largely driven by a signific...
Coherent Launches 224Gbps Quad TIA for Next-Generation AI and Cloud In...
Coherent Launches 224Gbps Quad TIA for Next-Generation AI and Cloud Infrastructure SAXONBURG, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier (TIA) designed to power next-generation 800G and 1.6T optical transceivers. Engineered for high-performance AI and cloud infrastructure, the CHR1074 combines ultra-fast link recovery with intelligent power management to improve efficiency and reduce latency in increasingly dynamic data center environments. As hy...
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2025 Result...
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2025 Results - Results Improved in All Segments - - Q4 2025 Gross Profit of $15.2 Million Increased $16.6 Million, Q4 2025 Net Income of $21.5 Million, or $0.28 per Share, Improved $63.5 Million, and Q4 2025 Adjusted EBITDA of $27.9 Million Grew $35.6 Million Compared to Q4 2024 - PEKIN, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter and year ended De...
Hudson Technologies Reports Fourth Quarter and Year-End 2025 Results
Hudson Technologies Reports Fourth Quarter and Year-End 2025 Results 28% growth in fourth quarter revenue to $44.4 millionAnnual refrigerant sales volume grew by 6% Annual refrigerant reclamation volume increased by 18% for second consecutive yearMaintained strong, unlevered balance sheet Completed accretive acquisition of Refrigerants Inc.Board approved $20 million share repurchase authorization for 2026 WOODCLIFF LAKE, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter and year ended December 31, 2025. Kenneth Gag...
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Rai...
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the fourth quarter and full year ended December 31, 2025 and raised guidance for full year 2026. Financial Highlights: Total revenue of $96.1 million in the fourth quarter of 2025, compared to $45.1 million in the fourth quarter of 2024,...
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2...
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2025 Results Fourth Quarter Results Total revenues of $50.6 million, a 13% year-over-year improvement and exceeding the high end of prior guidanceOperating income of $5.2 million increased 78% year-over-year, outpacing revenue growthNet income of $15.0 million ($5.34 per diluted share), including a net positive impact of $9.8 million related to the release of our deferred tax valuation allowanceAdjusted EBITDA of $9.2 million, compared to $8.2 million in the fourth quarter of 2024 and exceeding the high end of prior guida...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.